Cargando…
Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer
BACKGROUND: High-grade serous tubo-ovarian cancer (HGSC) is the most common histological subtype of epithelial ovarian cancer, and highly lethal. Currently there is no effective screening test and prognosis is poor as the majority of cases are diagnosed at the advanced stage. Cell free RNAs includin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717717/ https://www.ncbi.nlm.nih.gov/pubmed/35005155 http://dx.doi.org/10.1016/j.gore.2021.100894 |
_version_ | 1784624588736430080 |
---|---|
author | Hannan, Natalie J. Cohen, Paul A. Beard, Sally Bilic, Sanela Zhang, Bonnie Tong, Stephen Whitehead, Clare Hui, Lisa |
author_facet | Hannan, Natalie J. Cohen, Paul A. Beard, Sally Bilic, Sanela Zhang, Bonnie Tong, Stephen Whitehead, Clare Hui, Lisa |
author_sort | Hannan, Natalie J. |
collection | PubMed |
description | BACKGROUND: High-grade serous tubo-ovarian cancer (HGSC) is the most common histological subtype of epithelial ovarian cancer, and highly lethal. Currently there is no effective screening test and prognosis is poor as the majority of cases are diagnosed at the advanced stage. Cell free RNAs including microRNAs (miRNAs) are dysregulated in ovarian cancer tissue and are detectable in the circulation. This study aimed to determine whether circulating cell free miRNAs may be potential biomarkers for the detection of HGSC. METHODS: Plasma was collected from women with HGSC (Grade 3, n = 24), and benign ovarian masses (n = 24). RNA was extracted from patient plasma and subjected to miRNA targeted next generation sequencing (NGS). A subsequent validation cohort was assessed using plasma collected from women with HGSC (n = 14) and controls (with a benign ovarian mass; n = 15). RNA was extracted and assessed using quantitative RT-PCR. RESULTS: Differential gene expression (DGE) of the NGS data revealed a significant increase in the miRNA, miR200c, in the circulation of women with HGSC (p less than 0.05) compared to controls. In the validation cohort miR200c expression by qPCR was found to also be increased in the circulation of women with HGSC compared to controls (p = 0.0023). CONCLUSIONS: Circulating miR200c may be a promising candidate biomarker for the detection of HGSC. Further larger cohort studies exploring earlier stages are needed to determine whether circulating miR200c may be a sensitive and specific biomarker of tubo-ovarian cancer. |
format | Online Article Text |
id | pubmed-8717717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87177172022-01-06 Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer Hannan, Natalie J. Cohen, Paul A. Beard, Sally Bilic, Sanela Zhang, Bonnie Tong, Stephen Whitehead, Clare Hui, Lisa Gynecol Oncol Rep Research Report BACKGROUND: High-grade serous tubo-ovarian cancer (HGSC) is the most common histological subtype of epithelial ovarian cancer, and highly lethal. Currently there is no effective screening test and prognosis is poor as the majority of cases are diagnosed at the advanced stage. Cell free RNAs including microRNAs (miRNAs) are dysregulated in ovarian cancer tissue and are detectable in the circulation. This study aimed to determine whether circulating cell free miRNAs may be potential biomarkers for the detection of HGSC. METHODS: Plasma was collected from women with HGSC (Grade 3, n = 24), and benign ovarian masses (n = 24). RNA was extracted from patient plasma and subjected to miRNA targeted next generation sequencing (NGS). A subsequent validation cohort was assessed using plasma collected from women with HGSC (n = 14) and controls (with a benign ovarian mass; n = 15). RNA was extracted and assessed using quantitative RT-PCR. RESULTS: Differential gene expression (DGE) of the NGS data revealed a significant increase in the miRNA, miR200c, in the circulation of women with HGSC (p less than 0.05) compared to controls. In the validation cohort miR200c expression by qPCR was found to also be increased in the circulation of women with HGSC compared to controls (p = 0.0023). CONCLUSIONS: Circulating miR200c may be a promising candidate biomarker for the detection of HGSC. Further larger cohort studies exploring earlier stages are needed to determine whether circulating miR200c may be a sensitive and specific biomarker of tubo-ovarian cancer. Elsevier 2021-12-02 /pmc/articles/PMC8717717/ /pubmed/35005155 http://dx.doi.org/10.1016/j.gore.2021.100894 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Report Hannan, Natalie J. Cohen, Paul A. Beard, Sally Bilic, Sanela Zhang, Bonnie Tong, Stephen Whitehead, Clare Hui, Lisa Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer |
title | Transcriptomic analysis of patient plasma reveals circulating miR200c
as a potential biomarker for high-grade serous ovarian cancer |
title_full | Transcriptomic analysis of patient plasma reveals circulating miR200c
as a potential biomarker for high-grade serous ovarian cancer |
title_fullStr | Transcriptomic analysis of patient plasma reveals circulating miR200c
as a potential biomarker for high-grade serous ovarian cancer |
title_full_unstemmed | Transcriptomic analysis of patient plasma reveals circulating miR200c
as a potential biomarker for high-grade serous ovarian cancer |
title_short | Transcriptomic analysis of patient plasma reveals circulating miR200c
as a potential biomarker for high-grade serous ovarian cancer |
title_sort | transcriptomic analysis of patient plasma reveals circulating mir200c
as a potential biomarker for high-grade serous ovarian cancer |
topic | Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717717/ https://www.ncbi.nlm.nih.gov/pubmed/35005155 http://dx.doi.org/10.1016/j.gore.2021.100894 |
work_keys_str_mv | AT hannannataliej transcriptomicanalysisofpatientplasmarevealscirculatingmir200casapotentialbiomarkerforhighgradeserousovariancancer AT cohenpaula transcriptomicanalysisofpatientplasmarevealscirculatingmir200casapotentialbiomarkerforhighgradeserousovariancancer AT beardsally transcriptomicanalysisofpatientplasmarevealscirculatingmir200casapotentialbiomarkerforhighgradeserousovariancancer AT bilicsanela transcriptomicanalysisofpatientplasmarevealscirculatingmir200casapotentialbiomarkerforhighgradeserousovariancancer AT zhangbonnie transcriptomicanalysisofpatientplasmarevealscirculatingmir200casapotentialbiomarkerforhighgradeserousovariancancer AT tongstephen transcriptomicanalysisofpatientplasmarevealscirculatingmir200casapotentialbiomarkerforhighgradeserousovariancancer AT whiteheadclare transcriptomicanalysisofpatientplasmarevealscirculatingmir200casapotentialbiomarkerforhighgradeserousovariancancer AT huilisa transcriptomicanalysisofpatientplasmarevealscirculatingmir200casapotentialbiomarkerforhighgradeserousovariancancer |